JW Pharmaceutical Corporation (001065.KS) KSC

29,200.00

-100(-0.34%)

Updated at February 20 03:30PM

Currency In KRW

Valuation

Market Cap615.62B
Enterprise Value615.62B
P/E Ratio15.28
PEG Ratio11.24
Price/Sales Ratio1.16
Price/Book Ratio2.66
Enterprise/Revenue1.21
Enterprise/EBITDA8.59

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.12

Management Effectiveness

Return On Assets0.1
Return On Equity0.18

Income Statement

Revenue774.8B
Revenue/Share32,093.48
Gross Profit0
EBITDA93.63B
Net Income61.69B
Diluted EPS2,610.85

Balance Sheet

Total Cash82.51B
Total Cash/Share3,417.81
Total Debt68.66B
Total Debt/Equity0.19
Current Ratio1.51
Book Value Per Share14,667.38

Price History

52-Week Change-2.18
52-Week High30,300
52-Week Low26,550
Moving Average 50 Days28,916
Moving Average 200 Days28,573

Statistics

Average Volume475
Shares Outstanding17.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.18
Last Split Factor51:50
Last Split DateDecember 27, 2023